Helix 3 is necessary and sufficient for prion protein's anti-Bax function

Journal of Neurochemistry

Volumn 108, Issue 4, 2009, Pages 1019-1031

  Laroche Pierre, Stéphanie ^a,b   Jodoin, Julie ^a,b   LeBlanc, Andréa C ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

B cell lymphoma 2 associated protein X; Helix 3; MCF 7 cells; Neuron; Prion protein; Structure function

Indexed keywords

ALANINE; OCTAPEPTIDE; PRION PROTEIN; PROLINE; PROTEIN BAX;

ALPHA HELIX; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BETA SHEET; BRAIN NERVE CELL; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRUCTURE ACTIVITY RELATION;

ALANINE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; CELLS, CULTURED; CYTOPROTECTION; HUMANS; MICE; NEOPLASMS; NERVE DEGENERATION; PRION DISEASES; PROLINE; PROTEIN STRUCTURE, SECONDARY; PRPC PROTEINS;

EID: 58549104172     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05851.x     Document Type: Article

References (55)

1. Atarashi R., Nishida N., Shigematsu K., Goto S., Kondo T., Sakaguchi S. Katamine S. (2003) Deletion of N-terminal residues 23-88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/Doppel-induced neurodegeneration. J. Biol. Chem. 278, 28944 28949.
2. Blaber M., Zhang X. J. Matthews B. W. (1993) Structural basis of amino acid alpha helix propensity. Science 260, 1637 1640.
3. Bounhar Y., Zhang Y., Goodyer C. G. LeBlanc A. (2001) Prion protein protects human neurons against Bax-mediated apoptosis. J. Biol. Chem. 276, 39145 39149.
4. Bounhar Y., Mann K. K., Roucou X. LeBlanc A. C. (2006) Prion protein prevents Bax-mediated cell death in the absence of other Bcl-2 family members in Saccharomyces cerevisiae. FEMS Yeast Res. 6, 1204 1212.
5. Brown D. R., Schulz-Schaeffer W. J., Schmidt B. Kretzschmar H. A. (1997a) Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146, 104 112.
6. Brown D. R., Qin K., Herms J. W. et al. (1997b) The cellular prion protein binds copper in vivo. Nature 390, 684 687.
7. Brown D. R., Wong B. S., Hafiz F., Clive C., Haswell S. J. Jones I. M. (1999) Normal prion protein has an activity like that of superoxide dismutase. Biochem. J. 344 (Pt. 1 1 5.
8. Chiarini L. B., Freitas A. R., Zanata S. M., Brentani R. R., Martins V. R. Linden R. (2002) Cellular prion protein transduces neuroprotective signals. EMBO J. 21, 3317 3326.
9. Coulpier M., Messiaen S., Boucreaux D. Eloit M. (2006) Axotomy-induced motoneuron death is delayed in mice overexpressing PrPc. Neuroscience 141, 1827 1834.
10. DeLano W. L. (2002) The PyMOL Molecular Graphics System. DeLano Scientific, Palo Alto, CA.
11. Diarra-Mehrpour M., Arrabal S., Jalil A. et al. (2004) Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death. Cancer Res. 64, 719 727.
12. Donne D. G., Viles J. H., Groth D., Mehlhorn I., James T. L., Cohen F. E., Prusiner S. B., Wright P. E. Dyson H. J. (1997) Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc. Natl Acad. Sci. USA 94, 13452 13457.
13. Drisaldi B., Coomaraswamy J., Mastrangelo P. et al. (2004) Genetic mapping of activity determinants within cellular prion proteins: N-terminal modules in PrPC offset pro-apoptotic activity of the Doppel helix B/B′ region. J. Biol. Chem. 279, 55443 55454.
14. Dupiereux I., Falisse-Poirrier N., Zorzi W., Watt N. T., Thellin O., Zorzi D., Pierard O., Hooper N. M., Heinen E. Elmoualij B. (2007) Protective effect of prion protein via the N-terminal region in mediating a protective effect on paraquat-induced oxidative injury in neuronal cells. J. Neurosci. Res. 86, 653 659.
15. Ellgaard L. Helenius A. (2001) ER quality control: towards an understanding at the molecular level. Curr. Opin. Cell Biol. 13, 431 437.
16. Gallo M., Paludi D., Cicero D. O. et al. (2005) Identification of a conserved N-capping box important for the structural autonomy of the prion alpha 3-helix: the disease associated D202N mutation destabilizes the helical conformation. Int. J. Immunopathol. Pharmacol. 18, 95 112.
17. Jodoin J., Laroche-Pierre S., Goodyer C. G. LeBlanc A. C. (2007) Defective retrotranslocation causes loss of anti-Bax function in human familial prion protein mutants. J. Neurosci. 27, 5081 5091.
18. Karaivanova V. K. Spiro R. G. (2000) Effect of proteasome inhibitors on the release into the cytosol of free polymannose oligosaccharides from glycoproteins. Glycobiology 10, 727 735.
19. Kascsak R. J., Rubenstein R., Merz P. A., Tonna-DeMasi M., Fersko R., Carp R. I., Wisniewski H. M. Diringer H. (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61, 3688 3693.
20. Kiachopoulos S., Bracher A., Winklhofer K. F. Tatzelt J. (2005) Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor. J. Biol. Chem. 280, 9320 9329.
21. Kim Y., Lee J. Lee C. (2008) In silico comparative analysis of DNA and amino acid sequences for prion protein gene. Transbound. Emerg. Dis. 55, 105 114.
22. Kuwahara C., Takeuchi A. M., Nishimura T. et al. (1999) Prions prevent neuronal cell-line death. Nature 400, 225 226.
23. LeBlanc A. (1998) Unravelling the controversy of prion diseases, in Handbook of the Aging Brain (Wang E. Snyder S., eds), pp. 202 214. Academic Press, New York.
24. LeBlanc A. C., Papadopoulos M., Belair C., Chu W., Crosato M., Powell J. Goodyer C. G. (1997) Processing of amyloid precursor protein in human primary neuron and astrocyte cultures. J. Neurochem. 68, 1183 1190.
25. Li A. Harris D. A. (2005) Mammalian prion protein suppresses Bax-induced cell death in yeast. J. Biol. Chem. 280, 17430 17434.
26. Liang J., Pan Y. L., Ning X. X. et al. (2006) Overexpression of PrPC and its antiapoptosis function in gastric cancer. Tumour Biol. 27, 84 91.
27. Liemann S. Glockshuber R. (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochem. 38, 3258 3267.
28. Lin D. T., Jodoin J., Baril M., Goodyer C. G. LeBlanc A. C. (2008) Cytosolic prion protein is the predominant anti-Bax prion protein form: exclusion of transmembrane and secreted prion protein forms in the anti-Bax function. Biochim. Biophys. Acta Mol. Cell Res. 1783, 2001 2012.
29. Ma J. Lindquist S. (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc. Natl Acad. Sci. USA 98, 14955 14960.
30. McKinley M. P., Bolton D. C. Prusiner S. B. (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57 62.
31. Meslin F., Hamai A., Gao P., Jalil A., Cahuzac N., Chouaib S. Mehrpour M. (2007a) Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death. Cancer Res. 67, 10910 10919.
32. Meslin F., Conforti R., Mazouni C. et al. (2007b) Efficacy of adjuvant chemotherapy according to prion protein expression in patients with estrogen receptor-negative breast cancer. Ann. Oncol. 18, 1793 1798.
33. Mironov A. Jr., Latawiec D., Wille H., Bouzamondo-Bernstein E., Legname G., Williamson R. A., Burton D., DeArmond S. J., Prusiner S. B. Peters P. J. (2003) Cytosolic prion protein in neurons. J. Neurosci. 23, 7183 7193.
34. Mitteregger G., Vosko M., Krebs B., Xiang W., Kohlmannsperger V., Nolting S., Hamann G. F. Kretzschmar H. A. (2007) The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol. 17, 174 183.
35. Moore R. C., Mastrangelo P., Bouzamondo E., Heinrich C., Legname G., Prusiner S. B., Hood L., Westaway D., DeArmond S. J. Tremblay P. (2001) Doppel-induced cerebellar degeneration in transgenic mice. Proc. Natl Acad. Sci. USA 98, 15288 15293.
36. Muramoto T., DeArmond S. J., Scott M., Telling G. C., Cohen F. E. Prusiner S. B. (1997) Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alpha-helix. Nat. Med. 3, 750 755.
37. Nicolas O., Gavin R., Braun N., Urena J. M., Fontana X., Soriano E., Aguzzi A. Antonio del Rio J. (2007) Bcl-2 overexpression delays caspase-3 activation and rescues cerebellar degeneration in prion-deficient mice that overexpress amino-terminally truncated prion. FASEB J. 21, 3107 3117.
38. Prusiner S. B., Scott M. R., DeArmond S. J. Cohen F. E. (1998) Prion protein biology. Cell 93, 337 348.
39. Rachidi W., Vilette D., Guiraud P., Arlotto M., Riondel J., Laude H., Lehmann S. Favier A. (2003) Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J. Biol. Chem. 278, 9064 9072.
40. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R. Wuthrich K. (1996) NMR structure of the mouse prion protein domain PrP(121-321). Nature 382, 180 182.
41. Roucou X., Guo Q., Zhang Y., Goodyer C. G. LeBlanc A. C. (2003) Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J. Biol. Chem. 278, 40877 40881.
42. Roucou X., Gains M. LeBlanc A. C. (2004) Neuroprotective functions of prion protein. J. Neurosci. Res. 75, 153 161.
43. Roucou X., Giannopoulos P. N., Zhang Y., Jodoin J., Goodyer C. G. LeBlanc A. (2005) Cellular prion protein inhibits proapoptotic Bax conformational change in human neurons and in breast carcinoma MCF-7 cells. Cell Death Differ. 12, 783 795.
44. Shmerling D., Hegyi I., Fischer M., Blattler T., Brandner S., Gotz J., Rulicke T., Flechsig E., Cozzio A. von Mering C. (1998) Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93, 203 214.
45. Soule H. D., Vazguez J., Long A., Albert S. Brennan M. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst. 51, 1409 1416.
46. Swietnicki W., Petersen R. B., Gambetti P. Surewicz W. K. (1998) Familial mutations and the thermodynamic stability of the recombinant human prion protein. J. Biol. Chem. 273, 31048 31052.
47. Vanik D. L. Surewicz W. K. (2002) Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form. J. Biol. Chem. 277, 49065 49070.
48. Viles J. H., Cohen F. E., Prusiner S. B., Goodin D. B., Wright P. E. Dyson H. J. (1999) Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl Acad. Sci. USA 96, 2042 2047.
49. Walensky L. D. (2006) BCL-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ. 13, 1339 1350.
50. Walz R., Amaral O. B., Rockenbach I. C., Roesler R., Izquierdo I., Cavalheiro E. A., Martins V. R. Brentani R. R. (1999) Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 40, 1679 1682.
51. Yedidia Y., Horonchik L., Tzaban S., Yanai A. Taraboulos A. (2001) Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J. 20, 5383 5391.
52. Yin X.-M., Oltvai Z. N. Korsmeyer S. J. (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369, 321 323.
53. Zahn R., Liu A., Luhrs T., Riek R., von Schroetter C., Lopez Garcia F., Billeter M., Calzolai L., Wider G. Wuthrich K. (2000) NMR solution structure of the human prion protein. Proc. Natl Acad. Sci. USA 97, 145 150.
54. Zanata S. M., Lopes M. H., Mercadante A. F. et al. (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21, 3307 3316.
55. Zanusso G., Petersen R. B., Jin T., Jing Y., Kanoush R., Ferrari S., Gambetti P. Singh N. (1999) Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J. Biol. Chem. 274, 23396 23404.